Catherine (Katy) Todd is a Scientist at FHI 360, where she focuses on research in the areas of family planning and HIV disease, and leads technical design, support and operations research for integrated reproductive, maternal, newborn and child health programs.
Todd served as co-Principal Investigator, along with Professor Landon Myer at the University of Cape Town, for the U.S. National Institutes of Health-funded 2IUDnCT clinical trial. Within this trial, the study team evaluated efficacy of a checklist to determine reproductive tract infection risk and compared female genital tract sampling methods, contributing to the evidence base and guiding future study design and clinical practice. The study has produced five peer-reviewed publications to date.
Todd currently leads a process evaluation of virtual adaptations to a routine and emergency obstetric and newborn care training package in Mozambique and the effectiveness of a task-shifting model to optimize integrated service delivery in Kenya, and recently completed a nutrition service readiness and provider competence assessment in Afghanistan. She has expertise in the areas of quantitative analyses, and study and program design, as well as in maternal and newborn health, family planning and reproductive tract infections.
She received her MPH in population and family health from the Johns Hopkins Bloomberg School of Public Health, while completing a clinical Family Planning Fellowship at Johns Hopkins University. Todd received her MD from Indiana University School of Medicine and completed an Obstetrics & Gynecology residency at Washington University in St. Louis, Missouri.